comparemela.com

Latest Breaking News On - Clin endocrinol - Page 2 : comparemela.com

JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension

Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ as the first and only endothelin receptor.

Liechtenstein
Switzerland
Norway
Allschwil
Switzerland-general
Iceland
United-states
Australia
Swiss
America
Americans
Jean-paul-clozel

Is an at-home menopause test useful for women? Experts weigh in

Is an at-home menopause test useful for women? Experts weigh in
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Philadelphia
Pennsylvania
United-states
Colorado
Nanette-santoro
Richard-smith
E-stewart-taylor
Fiona-clancy
Stephanie-faubion
Byregina-schaffer
Twitter
University-of-colorado-school-medicine

Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 ...

BUCHAREST, Romania, Jan. 09, 2024 (GLOBE NEWSWIRE) Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced it has entered into an exclusive distribution agreement

Albania
Czech-republic
Lithuania
Hungary
Kosovo
Cyprus
Croatia
Bulgaria
Latvia
Turkey
Romania
Montenegro

Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey

Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Poland
Lithuania
Albania
Kosovo
Latvia
Macedonia
Bulgaria
Cyprus
Hungary
Greece
Montenegro
Slovenia

Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey

BUCHAREST, Romania, Jan. 09, 2024 Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced it has entered into an exclusive.

Estonia
Poland
Bulgaria
Latvia
Lithuania
Serbia
Albania
Malta
Slovenia
Kosovo
Cyprus
Turkey

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.